Literature DB >> 33653377

Recruitment of γδ T cells to the lesion via the CCL2/CCR2 signaling after spinal cord injury.

Ping Xu1, Feng Zhang2, Min-Min Chang3, Cheng Zhong4, Cheng-Hong Sun5, Hao-Ran Zhu1, Jing-Chun Yao5, Zhi-Zhong Li1,6, Si-Tao Li7, Wen-Cai Zhang8, Guo-Dong Sun9.   

Abstract

BACKGROUND: Immune cell infiltration and neuroinflammation are heavily associated with spinal cord injury (SCI). C-C motif chemokine ligand 2/C-C chemokine receptor type 2 (CCL2/CCR2) axis has been identified as a critical role player during the invasion of immune cells to lesions in many diseases. γδ T cells, a subgroup of T cells, manage the course of inflammation response in various diseases; however, it remains unknown whether γδ T cells are recruited to injury site through CCL2/CCR2 signaling and exert the regulation effect on neuroinflammation after SCI.
METHODS: Basso Mouse Scale (BMS), regularity index, cadence, max contact area, and motor-evoked potential testing (MEP) were measured to determine the neurological function recovery after spinal cord injury. Nissl staining was performed to identify the number of surviving motor neurons at lesion epicenter. Immunofluorescence, Western blot, enzyme-linked immunosorbent assays (ELISA), and quantitative real-time polymerase chain reaction (QRT-PCR) also were employed to evaluate the expression of associated proteins and genes.
RESULTS: In this study, we demonstrated that TCRδ-/- mice present improved neurological recovery after SCI. γδ T cell recruitment to the SCI site was significantly reduced and motor functional improvement enhanced in CCL2-/- and CCR2-/- mouse strains. Furthermore, reconstitution of TCRδ-/- mice with γδ T cells extracted from CCR2-/- mice also showed similar results to CCL2 and CCR2 deficient mice.
CONCLUSIONS: In conclusion, γδ T cell recruitment to SCI site promotes inflammatory response and exacerbates neurological impairment. CCL2/CCR2 signaling is a vital recruitment mechanism of γδ T cells to the SCI site, and it may be taken as a novel therapeutic target for future SCI.

Entities:  

Keywords:  CCL2; CCR2; Inflammation; Spinal cord injury; γδ T cell

Year:  2021        PMID: 33653377     DOI: 10.1186/s12974-021-02115-0

Source DB:  PubMed          Journal:  J Neuroinflammation        ISSN: 1742-2094            Impact factor:   8.322


  38 in total

1.  Differential immobilization and hierarchical involvement of chemokines in monocyte arrest and transmigration on inflamed endothelium in shear flow.

Authors:  K S Weber; P von Hundelshausen; I Clark-Lewis; P C Weber; C Weber
Journal:  Eur J Immunol       Date:  1999-02       Impact factor: 5.532

Review 2.  Global neurotrauma research challenges and opportunities.

Authors:  Andrés M Rubiano; Nancy Carney; Randall Chesnut; Juan Carlos Puyana
Journal:  Nature       Date:  2015-11-19       Impact factor: 49.962

3.  Global burden of traumatic brain and spinal cord injury.

Authors:  Jetan H Badhiwala; Jefferson R Wilson; Michael G Fehlings
Journal:  Lancet Neurol       Date:  2018-11-26       Impact factor: 44.182

4.  CCR2 antagonism alters brain macrophage polarization and ameliorates cognitive dysfunction induced by traumatic brain injury.

Authors:  Josh M Morganti; Timothy D Jopson; Sharon Liu; Lara-Kirstie Riparip; Cristian K Guandique; Nalin Gupta; Adam R Ferguson; Susanna Rosi
Journal:  J Neurosci       Date:  2015-01-14       Impact factor: 6.167

Review 5.  Role of gamma-delta (γδ) T cells in autoimmunity.

Authors:  Sourav Paul; Girdhari Lal
Journal:  J Leukoc Biol       Date:  2014-12-10       Impact factor: 4.962

Review 6.  Non Pharmacological Strategies to Promote Spinal Cord Regeneration: A View on Some Individual or Combined Approaches.

Authors:  Ivis-Ibrahim Morales; Diana Toscano-Tejeida; Antonio Ibarra
Journal:  Curr Pharm Des       Date:  2016       Impact factor: 3.116

Review 7.  Recent advances in managing a spinal cord injury secondary to trauma.

Authors:  Christopher S Ahuja; Allan R Martin; Michael Fehlings
Journal:  F1000Res       Date:  2016-05-27

8.  Interleukin-23 Secreted by Activated Macrophages Drives γδT Cell Production of Interleukin-17 to Aggravate Secondary Injury After Intracerebral Hemorrhage.

Authors:  Qi Zhong; Kai Zhou; Qiao-Li Liang; Sen Lin; Yan-Chun Wang; Xiao-Yi Xiong; Zhao-You Meng; Ting Zhao; Wen-Yao Zhu; Yuan-Rui Yang; Mao-Fan Liao; Qiu-Wen Gong; Liang Liu; Ao Xiong; Junwei Hao; Jian Wang; Qing-Wu Yang
Journal:  J Am Heart Assoc       Date:  2016-10-11       Impact factor: 5.501

9.  γδ T cells provide the early source of IFN-γ to aggravate lesions in spinal cord injury.

Authors:  Guodong Sun; Shuxian Yang; Guangchao Cao; Qianghua Wang; Jianlei Hao; Qiong Wen; Zhizhong Li; Kwok-Fai So; Zonghua Liu; Sufang Zhou; Yongxiang Zhao; Hengwen Yang; Libing Zhou; Zhinan Yin
Journal:  J Exp Med       Date:  2017-12-27       Impact factor: 14.307

Review 10.  The Role of Gamma-Delta T Cells in Diseases of the Central Nervous System.

Authors:  Jin Wo; Feng Zhang; Zhizhong Li; Chenghong Sun; Wencai Zhang; Guodong Sun
Journal:  Front Immunol       Date:  2020-10-23       Impact factor: 7.561

View more
  9 in total

1.  IL-27 Enhances γδ T Cell-Mediated Innate Resistance to Primary Hookworm Infection in the Lungs.

Authors:  Arjun Sharma; Jason B Noon; Konstantinos Kontodimas; Lucien P Garo; Johannes Platten; Lee J Quinton; Joseph F Urban; Christoph Reinhardt; Markus Bosmann
Journal:  J Immunol       Date:  2022-03-30       Impact factor: 5.426

2.  Revealing Potential Spinal Cord Injury Biomarkers and Immune Cell Infiltration Characteristics in Mice.

Authors:  Liang Cao; Qing Li
Journal:  Front Genet       Date:  2022-05-30       Impact factor: 4.772

3.  Activated γδ T Cells With Higher CD107a Expression and Inflammatory Potential During Early Pregnancy in Patients With Recurrent Spontaneous Abortion.

Authors:  Long Yu; Yang Zhang; Jinfeng Xiong; Jianjun Liu; Ying Zha; Qi Kang; Pan Zhi; Qiang Wang; Hui Wang; Wanjiang Zeng; Yafei Huang
Journal:  Front Immunol       Date:  2021-08-17       Impact factor: 7.561

4.  Small extracellular vesicles encapsulating CCL2 from activated astrocytes induce microglial activation and neuronal apoptosis after traumatic spinal cord injury.

Authors:  Yuluo Rong; Chengyue Ji; Zhuanghui Wang; Xuhui Ge; Jiaxing Wang; Wu Ye; Pengyu Tang; Dongdong Jiang; Jin Fan; Guoyong Yin; Wei Liu; Weihua Cai
Journal:  J Neuroinflammation       Date:  2021-09-12       Impact factor: 8.322

5.  Impairment of autophagy after spinal cord injury potentiates neuroinflammation and motor function deficit in mice.

Authors:  Yun Li; Zhuofan Lei; Rodney M Ritzel; Junyun He; Hui Li; Harry M C Choi; Marta M Lipinski; Junfang Wu
Journal:  Theranostics       Date:  2022-07-11       Impact factor: 11.600

6.  Inhibition of IL1R1 or CASP4 attenuates spinal cord injury through ameliorating NLRP3 inflammasome-induced pyroptosis.

Authors:  Chenfeng Wang; Hongdao Ma; Bangke Zhang; Tong Hua; Haibin Wang; Liang Wang; Lin Han; Qisheng Li; Weiqing Wu; Yulin Sun; Haisong Yang; Xuhua Lu
Journal:  Front Immunol       Date:  2022-08-05       Impact factor: 8.786

7.  Identification of hub genes related to the innate immune response activated during spinal cord injury.

Authors:  Jianfeng Li; Xizhe Liu; Huachuan Wu; Peng Guo; Baoliang Li; Jianmin Wang; Wei Tian; Dafu Chen; Manman Gao; Zhiyu Zhou; Shaoyu Liu
Journal:  FEBS Open Bio       Date:  2022-09-01       Impact factor: 2.792

8.  Dental pulp stem cell-derived exosomes suppress M1 macrophage polarization through the ROS-MAPK-NFκB P65 signaling pathway after spinal cord injury.

Authors:  Chao Liu; Fanqi Hu; Genlong Jiao; Yue Guo; Pan Zhou; Yuning Zhang; Zhen Zhang; Jing Yi; Yonggang You; Zhizhong Li; Hua Wang; Xuesong Zhang
Journal:  J Nanobiotechnology       Date:  2022-02-02       Impact factor: 10.435

9.  Exhausted and Apoptotic BALF T Cells in Proinflammatory Airway Milieu at Acute Phase of Severe Mycoplasma Pneumoniae Pneumonia in Children.

Authors:  Xi Chen; Fang Liu; Baoying Zheng; Xiaohui Kang; Xiaolin Wang; Wenjun Mou; Hui Zhang; Anxia Jiao; Shunying Zhao; Jingang Gui
Journal:  Front Immunol       Date:  2022-01-17       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.